You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
No matches

60 search results for: quality of life

EAACI 2023 | What is New in the Treatment <b>of</b> Children
expert video

EAACI 2023 | What is New in the Treatment of Children

Dermatology
Clinical trial and real-world data for targeted therapies for children with atopic dermatitis – Presentation from the ADVENT symposium at EAACI 2023.
View more
High Burden <b>of</b> Atopic Dermatitis in Children
expert video

High Burden of Atopic Dermatitis in Children

Dermatology
Explore the debilitating effects that impact day-to-day functioning in pediatric patients with atopic dermatitis – a short soundbite from EADV 2022.
View more
Trajectories <b>of</b> Type 2 Inflammation in Pediatric Patients
expert video

Trajectories of Type 2 Inflammation in Pediatric Patients

Type 2 Inflammation
Drs. Jonathan Spergel, Wanda Phipatanakul, Eric Simpson, Prof. Salvatore Oliva discuss pediatric patient/caregiver burden and multidisciplinary care
View more
The Burden <b>of</b> Atopic Dermatitis in Children – Daily Pruritis and Sleep Disturbance 
expert video

The Burden of Atopic Dermatitis in Children – Daily Pruritis and Sleep Disturbance 

Dermatology
Dr. Mark Koh provides insights on itch and its impact on sleep in children with AD.
View more
Type 2 Inflammation Alters the Structure and Function <b>of</b> the Skin in AD
expert video

Type 2 Inflammation Alters the Structure and Function of the Skin in AD

Dermatology
Highlights from the WCD 2023 ADVENT symposium, analyzing case studies and linked comorbidities in relation to atopic dermatitis and prurigo nodularis.
View more
Type 2 Inflammatory Disease Trajectories: Unraveling Patterns <b>of</b> Disease Development and Burden in Pediatric Patients
expert video

Type 2 Inflammatory Disease Trajectories: Unraveling Patterns of Disease Development and Burden in Pediatric Patients

Type 2 Inflammation
Dr. Leonard Bacharier presents potential disease trajectories and burden for pediatric patients with type 2 inflammatory diseases.
View more
Expert Insights: Importance <b>of</b> Lung Function Assessment in Pediatric Asthma Patients
expert video

Expert Insights: Importance of Lung Function Assessment in Pediatric Asthma Patients

Pulmonology
Dr. Michael Blaiss describes the importance of lung function assessment in pediatric asthma management
View more
Importance <b>of</b> Endotyping in CRSwNP
expert video

Importance of Endotyping in CRSwNP

Rhinology
Prof. Wytske Fokkens discusses the role of endotyping in the management of CRSwNP.
View more
Early Intervention in Children with Atopic Dermatitis: A Window <b>of</b> Opportunity?
expert video

Early Intervention in Children with Atopic Dermatitis: A Window of Opportunity?

Dermatology
Highlights from the ESPD 2023 ADVENT symposium, exploring burden, skin barrier normalization, and current treatments for pediatric atopic dermatitis.
View more
Beyond the Signs ​and Symptoms: ​The Developmental Burden <b>of</b> AD in Children
expert video

Beyond the Signs ​and Symptoms: ​The Developmental Burden of AD in Children

Dermatology
Highlights from the ESPD 2023 ADVENT symposium: Exploring burden and comorbidities associated with moderate-to-severe atopic dermatitis in children.
View more

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2025 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 v3.0 11/2023

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: GreeceChange country/region